Rize Medical Journal, cilt.1, sa.1, ss.1-7, 2025 (Hakemli Dergi)
Aim: Colorectal cancer is a leading cause of cancer-related
mortality, due to therapy resistance and metastasis. This
study explored the role of Notch signaling in colorectal
cancer by comparing the expression of pathway-associated
genes between healthy CCD841-con cells and HCT116
colorectal cancer cells.
Findings: Semi-quantitative PCR analysis revealed
significant upregulation of GATA3 (4-fold), HES1 (5-
fold), and HEY1 (3-fold) in HCT116 cells, while PTCRA
expression decreased 4-fold (p<0.005, normalized to
GAPDH). These results suggest that Notch signaling
contributes to tumor progression in colorectal cancer. The
elevated expression of HES1 and HEY1 may be linked to
epithelial-mesenchymal transition and cancer stem cell-
like traits.
Conclusion: Overall, this study highlights the potential of
targeting the Notch pathway in colorectal cancer therapy,
offering insights into its role in tumor development and
resistance mechanisms.